Marc Nemitz

Recent articles by Marc Nemitz

News NORBr with 3 million euro financing round NORBr plans to use EUR 3 million to scale its no-code platform for PSPs and acquirers globally - Alstin Capital is leading the round.

Marc Nemitz 25.11.2024

News AWS and Anthropic expand partnership with $4 billion investment Amazon invests 4 billion dollars in Anthropic: New partnership drives AI development from hardware to the cloud

Marc Nemitz 25.11.2024

News Startupnews week 47 - 2024 Lighthouse secures 370 million US dollars in Series C. FOUNDERS JAM in Wolfenbüttel. Eye-Able® receives 20 million euros. Xayn launches legal AI Noxtua Research. N26 achieves first quarterly profit. Fairown and...

Marc Nemitz 22.11.2024

News Candela secures 40 million US dollars for emission-free hydrofoils Swedish company Candela has successfully closed a USD 40 million funding round to scale production of its electric hydrofoils and drive the decarbonization of water transport.

Marc Nemitz 21.11.2024

News Cardo AI secures 15 million dollars in Series A Blackstone and FINTOP invest. Cardo AI is modernizing the market for asset-based financing with AI and data-based solutions.

Marc Nemitz 21.11.2024

News KoRo receives 35 million euros in Series C Snacking market leader on course for growth: KoRo impresses investors and plans sales growth of over 50% for 2024

Marc Nemitz 21.11.2024

News FertilAI secures 4.5 million dollars 4.5 million dollars for family planning: FertilAI uses AI to increase the chances of success in fertility medicine - and receives prominent investor support.

Marc Nemitz 21.11.2024

News Relocraft receives financing from ESB Invest The startup Relocraft secures financing from ESB Invest and relocates its headquarters from Hamburg to Greifswald.

Marc Nemitz 20.11.2024

News Firsty secures 5.1 million euros Fresh capital for free Internet access. The Amsterdam start-up eliminates roaming charges and enables free mobile data traffic worldwide.

Marc Nemitz 20.11.2024

News ATB Therapeutics secures 54 million euros in Series A ATB Therapeutics secures fresh capital for innovative antibodies. EQT Life Sciences and partners invest in breakthrough antibody therapies for oncology and immunology.

Marc Nemitz 20.11.2024

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• 73
• 74
• 75
• 76
• 77
• 78
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• 94
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• 103
• 104
• 105
• 106
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• 114
• 115
• 116
• 117
• 118
• 119
• 120
• 121
• 122
• 123
• 124
• 125
• 126
• 127
• 128
• 129
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• 142
• 143